Finance

Lists
600998:SHA
Jointown Pharmaceutical Group Co Ltd
4,93 CN¥
-1,79%
(-0,090) 1D
16 հոկ, 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600998...
Open
5,02 CN¥
High
5,08 CN¥
Low
4,88 CN¥
Mkt. cap
24,86 մլրդ
Avg. vol.
33,74 մլն
Volume
44,94 մլն
Dividend
4,06%
Quarterly dividend
0,05 CN¥
Ex-dividend date
08 հնս, 2026 թ.
P/E ratio
12,56
52-wk high
5,84 CN¥
52-wk low
4,48 CN¥
EPS
0,39 CN¥
Shares outstanding
1,88 մլրդ
No. of employees
30 հզր
Open
5,02 CN¥
High
5,08 CN¥
Low
4,88 CN¥
Mkt. cap
24,86 մլրդ
Avg. vol.
33,74 մլն
Volume
44,94 մլն
Dividend
4,06%
Quarterly dividend
0,05 CN¥
Ex-dividend date
08 հնս, 2026 թ.
P/E ratio
12,56
52-wk high
5,84 CN¥
52-wk low
4,48 CN¥
EPS
0,39 CN¥
Shares outstanding
1,88 մլրդ
No. of employees
30 հզր
News stories
From web sources and news partners
Profile
Jointown Pharmaceutical Group Co., Ltd. is a publicly traded multinational healthcare services company. By revenue, it is the largest medical company in China that is not state-owned. It is also the 4th largest overall. Its global headquarters are in Wuhan, China and its international headquarters are in Los Angeles, California. The company specializes in the distribution of pharmaceuticals and medical products, distributing more than 510,000 products. The company also manufactures products, including gloves, surgical masks, medical equipment and medications. In addition, it operates the largest network of medical warehouses in China. It is one of the largest in the world, at over 44 million square feet. The company has over 400 subsidiaries and provides medical products to all 31 provinces in mainland China. Wikipedia
About Jointown Pharmaceutical Group Co Ltd
CEO-
Employees29,9 հզր
Founded2000
Headquarters-
SectorHealth care provider
Websitejointown.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
38,22 մլրդ
42,06 մլրդ
44,78 մլրդ
42,50 մլրդ
Cost of goods sold
35,00 մլրդ
38,94 մլրդ
41,44 մլրդ
39,12 մլրդ
Cost of revenue
35,00 մլրդ
38,94 մլրդ
41,44 մլրդ
39,12 մլրդ
Research and development expenses
31,00 մլն
31,05 մլն
24,25 մլն
35,77 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,07 մլրդ
2,21 մլրդ
2,07 մլրդ
2,24 մլրդ
Operating expense
2,18 մլրդ
2,54 մլրդ
2,37 մլրդ
2,45 մլրդ
Total operating expenses
37,17 մլրդ
41,49 մլրդ
43,81 մլրդ
41,57 մլրդ
Operating income
1,05 մլրդ
577,21 մլն
971,28 մլն
922,06 մլն
Other non operating income
-10,19 մլն
-23,03 մլն
-15,38 մլն
-57,14 մլն
EBT including unusual items
706,81 մլն
590,98 մլն
762,47 մլն
810,81 մլն
EBT excluding unusual items
868,16 մլն
402,66 մլն
702,61 մլն
619,67 մլն
Income tax expense
148,37 մլն
258,61 մլն
167,28 մլն
213,41 մլն
Effective tax rate
20,99%
43,76%
21,94%
26,32%
Other operating expenses
7,64 մլն
209,56 մլն
45,26 մլն
169,00 մլն
Net income
529,89 մլն
279,41 մլն
733,16 մլն
467,41 մլն
Net profit margin
1,39%
0,66%
1,64%
1,10%
Earnings per share
0,10
0,05
0,11
0,08
Interest and investment income
65,37 մլն
122,28 մլն
65,73 մլն
31,49 մլն
Interest expense
-245,91 մլն
-262,58 մլն
-319,03 մլն
-279,26 մլն
Net interest expenses
-180,54 մլն
-140,30 մլն
-253,30 մլն
-247,77 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,22 մլրդ
728,70 մլն
1,12 մլրդ
1,11 մլրդ
Gain or loss from assets sale
-238,51 մլն
244,27 մլն
-
20,61 մլն
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps